White papers

How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms

Scientific Team — Mon, 06 Jul 2026 13:52:27 GMT

In our previous article, we explored how early active pharmaceutical ingredient (API) characterization can reduce formulation and scale-up risks. The next step is to use the knowledge gained on the API and make the optimal formulation to deliver the drug efficiently and safely at the site of action.

How Early API Characterization Can Reduce Formulation and Scale-up Risks

Scientific Team — Fri, 03 Jul 2026 20:40:55 GMT

1. Where does api characterization fit in product development?

As soon as an active pharmaceutical ingredient (API) is discovered, companies race against time to market a finished drug product. As the saying goes, time is money! The work done upstream can prevent obstacles along the way to smoothly reach the finish line.